Bruker Corporation logo

Bruker Corporation

BRKRP | NASDAQ
Chart Builder DCF Calculator
$414.00
-$8.39 (-1.99%)
Nov 2, 2026, 9:32 AM ET · Market open

Company Profile

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions. It operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies. The company offers magnetic resonance spectroscop, preclinical imaging, biopharma and applied, services and lifecycle support, integrated data solution, and automation; life science tools; innovative nuclear magnetic resonance (NMR) and electron paramagnetic resonance (EPR) products; solutions for in-vivo processes and drug discovery; aftermarket solutions; solutions for lab automation and digitalization; mass spectrometry solution and test kits, DNA test strips, and fluorescence-based PCR technologies; genotype and fluorotype molecular diagnostics kits; and research, analytical, and process analysis instruments and solutions. It also provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; services for transcriptional profiling and multiomic analysis; superconducting materials, such as metallic low temperature superconductors; multifilament round and rectangular LTS wires in both monolithic and wire-in-channel formats; designs and manufactures Cuponal; metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. Bruker Corporation was founded in 1960 and is headquartered in Billerica, Massachusetts.

Key Executives

Name Position
Burkhard Prause President and Chief Executive Officer of Bruker Energy & Supercon Technologies, Inc.
Frank H. Laukien Chairman, Chief Executive Officer & President
Gerald N. Herman Executive Vice President & Chief Financial Officer
Falko Busse President of Bruker BioSpin Group
J. Brent Alldredge Senior Vice President, General Counsel, Secretary & Global Head of Compliance
Juergen Srega President of Bruker Biosystems Group & Bruker Daltonics Division
Mark R. Munch Corporate Executive Vice President and President of Bruker Nano Group & Corporate
Thomas Bures Chief Accounting Officer
Wolfgang Pusch President of Bruker Microbiology & Infection Diagnostics Group

Latest SEC Filings

Date Type Title
Sep 16, 2026 4 Filing
Aug 18, 2026 4 Filing
Aug 18, 2026 4 Filing
Aug 18, 2026 4 Filing
Aug 18, 2026 4 Filing
Aug 18, 2026 4 Filing
Aug 18, 2026 4 Filing
Aug 18, 2026 4 Filing
Aug 14, 2026 8-K Current Report
Aug 13, 2026 4 Filing
View All SEC Filings ➞
Bruker Corporation
Bruker Corporation logo
Country United States
IPO Date Sep 4, 2025
Industry Medical - Devices
Sector Healthcare
Employees 11,085
CEO Frank H. Laukien

Contact Details

40 Manning Road Billerica, Massachusetts 01821 United States

Stock Details

Ticker Symbol BRKRP
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001109354
CUSIP Number 116794207
ISIN Number US1167942077
SIC Code 3826

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.